MapLight Therapeutics, Inc. (MPLT) Current Reports & Earnings Releases
Upcoming
- 2026-12-03 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-13 | 8-K | Material Agreement, Results of Operations, Unregistered Sales, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-07-27 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-24 | 8-K | Shareholder Vote Results | SEC |
| 2026-06-22 | 8-K | Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-06-18 | 8-K | Officer / Director Changes | SEC |
| 2026-05-14 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-04-29 | 8-K | Officer / Director Changes | SEC |
| 2026-03-26 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2026-01-09 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-12-04 | 8-K | Results of Operations, Reg FD Disclosure, Financial Statements & Exhibits | SEC |
| 2025-10-29 | 8-K | Unregistered Sales, Charter Amendments, Other Events, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.